Broadfin Capital’s Medtronic MDT Stock Holding History

Broadfin Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-75,000	Closed	-$5.34M	–	57
2016 Q4	$5.34M	Buy	+75,000	New	+$5.89M	0.59%	41

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Broadfin Capital's MDT Position: Q1 2017 in Review

Broadfin Capital sold out of Medtronic (MDT) in Q1 2017, closing a stake of 75,000 shares — an estimated $5.34M sold.

Broadfin Capital first reported a position in MDT in Q4 2016 and held it in 1 quarter. The position peaked at $5.34M in Q4 2016. 1,283 funds tracked by Wall St. Rank hold MDT as of Q1 2017.

Broadfin Capital reported no remaining Medtronic position as of Q1 2017 after selling out during the quarter.
Broadfin Capital sold 75,000 Medtronic shares in Q1 2017, an estimated $5.34M.
Broadfin Capital first reported a position in Medtronic in Q4 2016 and held it in 1 quarter.
Broadfin Capital's Medtronic position peaked at $5.34M in Q4 2016.
1,283 funds tracked by Wall St. Rank held Medtronic as of Q1 2017.

Based on Broadfin Capital's 13F filing for Q1 2017, filed 15 May 2017.